GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Margin of Safety % (DCF FCF Based)

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Margin of Safety % (DCF FCF Based) : -2,146.46% (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is Carl Zeiss Meditec AG Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-04-30), Carl Zeiss Meditec AG's Predictability Rank is 3.5-Stars. Carl Zeiss Meditec AG's intrinsic value calculated from the Discounted FCF model is $82.10 and current share price is $111.20. Consequently,

Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -2,146.46%.


Competitive Comparison of Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based)

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based) falls into.



Carl Zeiss Meditec AG Margin of Safety % (DCF FCF Based) Calculation

Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(4.95-111.20)/4.95
=-2,146.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.


Carl Zeiss Meditec AG Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.